<SEC-DOCUMENT>0001178913-24-003893-index.html : 20241202 <SEC-HEADER>0001178913-24-003893.hdr.sgml : 20241202 <ACCEPTANCE-DATETIME>20241202162212 ACCESSION NUMBER: 0001178913-24-003893 CONFORMED SUBMISSION TYPE: POS AM PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20241202 DATE AS OF CHANGE: 20241202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chemomab Therapeutics Ltd. CENTRAL INDEX KEY: 0001534248 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 813676773 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: POS AM SEC ACT: 1933 Act SEC FILE NUMBER: 333-255249 FILM NUMBER: 241519352 BUSINESS ADDRESS: STREET 1: KIRYAT ATIDIM, BUILDING 7 CITY: TEL AVIV STATE: L3 ZIP: 6158002 BUSINESS PHONE: 972-77-331-0156 MAIL ADDRESS: STREET 1: KIRYAT ATIDIM, BUILDING 7 CITY: TEL AVIV STATE: L3 ZIP: 6158002 FORMER COMPANY: FORMER CONFORMED NAME: Anchiano Therapeutics Ltd. DATE OF NAME CHANGE: 20180906 FORMER COMPANY: FORMER CONFORMED NAME: BioCancell Ltd. DATE OF NAME CHANGE: 20111104 </SEC-HEADER> <DOCUMENT> <TYPE>POS AM <SEQUENCE>1 <FILENAME>zk2432420.htm <DESCRIPTION>POS AM <TEXT> Document 1 - file: zk2432420.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>exhibit_5-1.htm <DESCRIPTION>EXHIBIT 5.1 <TEXT> Document 2 - file: exhibit_5-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>exhibit_23-1.htm <DESCRIPTION>EXHIBIT 23.1 <TEXT> Document 3 - file: exhibit_23-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>4 <FILENAME>exhibit_107.htm <DESCRIPTION>FILING FEES TABLE <TEXT> Document 4 - file: exhibit_107.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>image00003.jpg <TEXT> Document 5 - file: image00003.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>image00004.jpg <TEXT> Document 6 - file: image00004.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>image00005.jpg <TEXT> Document 7 - file: image00005.jpg
</DOCUMENT> </SEC-DOCUMENT>